相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak et al.
GENETICS IN MEDICINE (2022)
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
Bart Koopman et al.
ONCOLOGIST (2021)
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
S. S. Ramalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
Mario Lamping et al.
EUROPEAN JOURNAL OF CANCER (2020)
Molecular profiling for precision cancer therapies
Eoghan R. Malone et al.
GENOME MEDICINE (2020)
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Alex H. Wagner et al.
NATURE GENETICS (2020)
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
Shumei Kato et al.
NATURE COMMUNICATIONS (2020)
Variant classification in precision oncology
Jonas Leichsenring et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon et al.
NATURE MEDICINE (2019)
VIST-a Variant-Information Search Tool for precision oncology
Jurica Seva et al.
BMC BIOINFORMATICS (2019)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comparison of Treatment Recommendations by Molecular Tumor Boards Worldwide
Damian T. Rieke et al.
JCO PRECISION ONCOLOGY (2018)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Malachi Griffith et al.
NATURE GENETICS (2017)
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Christophe Massard et al.
CANCER DISCOVERY (2017)
Somatic cancer variant curation and harmonization through consensus minimum variant level data
Deborah I. Ritter et al.
GENOME MEDICINE (2016)
A Decision Support Framework for Genomically Informed Investigational Cancer Therapy
Funda Meric-Bernstam et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Decision Support Framework for Genomically Informed Investigational Cancer Therapy
Funda Meric-Bernstam et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Prioritizing targets for precision cancer medicine
F. Andre et al.
ANNALS OF ONCOLOGY (2014)
Organizing knowledge to enable personalization of medicine in cancer
Benjamin M. Good et al.
GENOME BIOLOGY (2014)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
分享论文
